CareDx Inc (CDNA)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
SERVICES-MEDICAL LABORATORIES
CEO:
Reginald Seeto
Employees:
740
3260 BAYSHORE BOULEVARD, BRISBANE, CA 94005
415-287-2300

CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients. AlloSeq Tx, a high-resolution HLA typing solution, is used to type human leukocyte antigen (HLA) alleles.

Data derived from most recent annual or quarterly report
Market Cap 371.598 Million Shares Outstanding54.169 Million Avg 30-day Volume 636.917 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.46
Price to Revenue1.4797 Debt to Equity0.0 EBITDA-75.78 Million
Price to Book Value1.1295 Operating Margin-28.582400000000003 Enterprise Value175.02 Million
Current Ratio4.843 EPS Growth-0.182 Quick Ratio4.488
1 Yr BETA 0.9814 52-week High/Low 20.71 / 6.22 Profit Margin-27.1479
Operating Cash Flow Growth101.3367 Free Cash Flow to Firm (FCFF) TTM -46.716 Million Free Cash Flow to Equity (FCFE) TTM-75.141 Million
Altman Z-Score1.7966
Earnings Report2023-11-02
View SEC Filings from CDNA instead.

View recent insider trading info

CareDx Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding CDNA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CDNA

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-10-02 by SEETO REGINALD
  • 4: filed on 2023-09-26 by RONAI ABRAHAM
  • 4: filed on 2023-09-11 by JAIN ABHISHEK
  • 4: filed on 2023-09-11 by RONAI ABRAHAM
  • 4: filed on 2023-09-08 by JAIN ABHISHEK
  • 4: filed on 2023-09-05 by SEETO REGINALD
  • 4: filed on 2023-08-14 by SEETO REGINALD
  • 4: filed on 2023-08-11 by BICKERSTAFF GEORGE
  • 4: filed on 2023-08-09 by SEETO REGINALD
  • 4: filed on 2023-08-09 by JOHNSON ALEXANDER L

    • Events (8k)

  • 8-K: filed on 2023-09-26:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-09-25:
    Item 8.01: Other Events
  • 8-K: filed on 2023-08-08:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-06-20:
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-05-10:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-04-03:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-03-28:
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-01-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-12-06:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-23:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

  • 144: filed on 2023-04-03:
  • 144: filed on 2023-05-02:
  • 144: filed on 2023-06-02:
  • 144: filed on 2023-06-28:
  • 144: filed on 2023-06-28:
  • 144: filed on 2023-07-03:
  • 144: filed on 2023-07-13:
  • 144: filed on 2023-07-13:
  • 144: filed on 2023-08-02:
  • 144: filed on 2023-08-14:

    • Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    6.2 Thousand total shares from 3 transactions

    Exercise Derivative Conversion (M)

    19.5 Thousand total shares from 3 transactions

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    SEETO REGINALD SEE REMARKS

    • Officer
    • Director
    		 479,164 2023-10-02 21

    RONAI ABRAHAM SEE REMARKS

    • Officer
    		 515,986 2023-09-20 7

    JAIN ABHISHEK CHIEF FINANCIAL OFFICER

    • Officer
    		 130,561 2023-09-07 6

    BICKERSTAFF GEORGE

    • Director
    		 99,721 2023-08-11 5

    JOHNSON ALEXANDER L CHIEF BUSINESS OFFICER

    • Officer
    		 188,591 2023-08-07 8

    MAAG PETER

    • Director
    		 309,657 2023-07-13 9

    GOLDBERG MICHAEL

    • Director
    		 96,799 2023-07-06 5

    HAGSTROM WILLIAM A

    • Director
    		 43,409 2023-06-16 1

    COURNOYER CHRISTINE

    • Director
    		 39,335 2023-06-16 2

    TORRES ARTHUR A

    • Director
    		 26,562 2023-06-16 1

    COHEN FRED E

    • Director
    		 132,592 2023-06-16 3

    COLON GRACE

    • Director
    		 23,708 2023-06-16 1

    VALANTINE HANNAH

    • Director
    		 26,891 2023-06-16 3

    SNYDERMAN RALPH

    • Director
    		 58,177 2022-10-04 1

    KING SASHA CHIEF MARKETING OFFICER

    • Officer
    		 140,580 2022-08-09 0

    DHINGRA ANKUR CHIEF FINANCIAL OFFICER

    • Officer
    		 38,146 2022-03-25 0

    KONRAD MARCEL SEE REMARKS

    • Officer
    		 13,864 2020-12-31 0

    BELL MICHAEL BRIAN CHIEF FINANCIAL OFFICER

    • Officer
    		 103,343 2020-11-03 0

    YEE JAMES P CHIEF MEDICAL OFFICER

    • Officer
    		 42,045 2019-07-01 0

    ABERNETHY AMY

    • Director
    		 15,837 2019-01-22 0

    MAAG PETER SEE REMARKS

    MAAG PETER SEE REMARKS

    • Officer
    • Director
    		 393,747 2018-11-13 9

    GAGNON NEIL

    • 10% Owner
    		 No longer subject to file 2018-10-31 0

    NELLES MITCHELL J CHIEF OPERATING OFFICER

    • Officer
    		 86,889 2018-06-29 0

    SNINSKY JOHN JOSEPH CHIEF SCIENTIFIC OFFICER

    • Officer
    		 22,309 2018-01-29 0

    KARLSSON ANDERS CHIEF COMMERCIAL OFFICER

    • Officer
    		 9,638 2018-01-19 0

    MIDROC INVEST AB

    • 10% Owner
    		 1,967,436 2017-07-03 0

    MILLER DOUGLAS S

    • Director
    		 17,695 2017-04-01 0

    CONSTANTI CHARLES CHIEF FINANCIAL OFFICER

    • Officer
    		 10,000 2017-02-17 0

    WHITSON TODD CHIEF COMMERCIAL OFFICER

    • Officer
    		 20,000 2017-02-17 0

    BYERS BROOK H

    • FORMER DIRECTOR
    		 No longer subject to file 2016-07-01 0

    LUDLUM KEN CHIEF FINANCIAL OFFICER

    • Officer
    		 48,000 2016-01-22 0

    MEYER MATTHEW J. CHIEF BUSINESS OFFICER

    • Officer
    		 23,025 2016-01-22 0

    DEFONZO JOSHUA CHIEF COMMERCIAL OFFICER

    • Officer
    		 11,000 2016-01-22 0

    TPG GROUP HOLDINGS (SBS) ADVISORS, INC.

    BONDERMAN DAVID

    COULTER JAMES G

    • 10% Owner
    		 1,075,090 2014-07-22 0

    KLEINER PERKINS CAUFIELD & BYERS X A LP

    KLEINER PERKINS CAUFIELD & BYERS X B LP

    KPCB X ASSOCIATES LLC

    • 10% Owner
    		 1,449,578 2014-07-21 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    SEETO REGINALD - Director - Officer SEE REMARKS

    		2023-10-02 19:53:42 -0400 2023-10-02 S 2,818 $6.91 d 479,164 direct yes

    RONAI ABRAHAM - Officer SEE REMARKS

    		2023-09-26 17:24:59 -0400 2023-09-20 A 360,000 a 515,986 direct -4.4776 0.0 1 -4.4776 2

    RONAI ABRAHAM - Officer SEE REMARKS

    		2023-09-11 19:55:18 -0400 2023-09-07 F 1,465 $8.26 d 155,986 direct -1.1765 -5.6471 0.0 1 -6.9412 5

    JAIN ABHISHEK - Officer CHIEF FINANCIAL OFFICER

    		2023-09-11 19:55:35 -0400 2023-09-07 F 2,746 $8.26 d 130,561 direct -1.1765 -5.6471 0.0 1 -6.9412 5

    JAIN ABHISHEK - Officer CHIEF FINANCIAL OFFICER

    		2023-09-08 19:17:19 -0400 2023-09-06 F 1,054 $8.81 d 133,307 direct 2.0408 -5.042 2.0408 2 -5.042 6

    SEETO REGINALD - Director - Officer SEE REMARKS

    		2023-09-05 16:03:23 -0400 2023-09-05 S 2,819 $9.49 d 481,982 direct yes -6.2429 -4.6538 0.0 1 -7.2645 3

    SEETO REGINALD - Director - Officer SEE REMARKS

    		2023-08-14 19:52:12 -0400 2023-08-14 S 576 $8.89 d 484,801 direct yes -9.5238 -13.2505 -23.706 0.7246 14 -23.8095 30

    BICKERSTAFF GEORGE - Director

    		2023-08-11 19:47:25 -0400 2023-08-11 M 4,453 $5.49 a 99,721 direct 3.3155 -7.8075 -21.2834 4.0642 15 -21.2834 31

    BICKERSTAFF GEORGE - Director

    		2023-08-11 19:47:25 -0400 2023-08-11 M 4,453 d 2,226 direct

    BICKERSTAFF GEORGE - Director

    		2023-08-11 19:47:25 -0400 2023-08-11 M 5,255 $5.02 a 85,523 direct 3.3155 -7.8075 -21.2834 4.0642 15 -21.2834 31

    BICKERSTAFF GEORGE - Director

    		2023-08-11 19:47:25 -0400 2023-08-11 M 5,255 d 0 direct

    BICKERSTAFF GEORGE - Director

    		2023-08-11 19:47:25 -0400 2023-08-11 M 9,745 $4.95 a 95,268 direct 3.3155 -7.8075 -21.2834 4.0642 15 -21.2834 31

    BICKERSTAFF GEORGE - Director

    		2023-08-11 19:47:25 -0400 2023-08-11 M 9,745 d 0 direct

    JOHNSON ALEXANDER L - Officer CHIEF BUSINESS OFFICER

    		2023-08-09 20:23:44 -0400 2023-08-07 F 217 $10.80 d 188,591 direct -8.0579 -12.5 -20.8678 0.5165 17 -20.8678 31

    SEETO REGINALD - Director - Officer SEE REMARKS

    		2023-08-09 20:24:14 -0400 2023-08-07 F 674 $10.80 d 485,377 direct -8.0579 -12.5 -20.8678 0.5165 17 -20.8678 31

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    CAREDX INC CDNA 2023-10-03 20:45:04 UTC 4.7644 0.5556 1100000
    CAREDX INC CDNA 2023-10-03 20:15:04 UTC 4.7644 0.5556 1100000
    CAREDX INC CDNA 2023-10-03 19:45:04 UTC 4.7644 0.5556 1100000
    CAREDX INC CDNA 2023-10-03 19:15:04 UTC 4.7644 0.5556 1100000
    CAREDX INC CDNA 2023-10-03 18:45:05 UTC 4.7644 0.5556 1100000
    CAREDX INC CDNA 2023-10-03 18:15:03 UTC 0.0 0.0 1100000
    CAREDX INC CDNA 2023-10-03 17:45:04 UTC 4.7313 0.5887 1100000
    CAREDX INC CDNA 2023-10-03 17:15:04 UTC 4.7313 0.5887 1100000
    CAREDX INC CDNA 2023-10-03 16:45:04 UTC 4.7313 0.5887 1100000
    CAREDX INC CDNA 2023-10-03 16:15:04 UTC 4.7313 0.5887 1100000
    CAREDX INC CDNA 2023-10-03 15:45:04 UTC 4.5655 0.7545 1100000
    CAREDX INC CDNA 2023-10-03 15:15:05 UTC 4.5655 0.7545 1100000
    CAREDX INC CDNA 2023-10-03 14:45:04 UTC 4.5655 0.7545 1100000
    CAREDX INC CDNA 2023-10-03 14:15:04 UTC 4.5655 0.7545 1100000
    CAREDX INC CDNA 2023-10-03 13:45:03 UTC 4.4615 0.8585 1100000
    CAREDX INC CDNA 2023-10-03 13:15:04 UTC 4.4615 0.8585 1100000
    CAREDX INC CDNA 2023-10-03 12:45:04 UTC 4.4615 0.8585 700000
    CAREDX INC CDNA 2023-10-02 22:15:03 UTC 4.4615 0.8585 1000000
    CAREDX INC CDNA 2023-10-02 21:45:03 UTC 4.4615 0.8585 1000000
    CAREDX INC CDNA 2023-10-02 21:15:04 UTC 4.4615 0.8585 1000000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    FundVantage Trust- Gotham Enhanced Index Plus Fund CDNA -117.0 shares, $-2554.11 2020-03-31 N-PORT
    FundVantage Trust- Gotham Defensive Long Fund CDNA -126.0 shares, $-2750.58 2020-03-31 N-PORT
    FundVantage Trust- Gotham Index Plus All-Cap Fund CDNA -262.0 shares, $-5719.46 2020-03-31 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments